Skip to main content
Premium Trial:

Request an Annual Quote

DNA Print Secures $8M in Debenture Financing

NEW YORK, Dec. 3 (GenomeWeb News) - DNA Print Genomics said today that La Jolla Cove Investors has committed to invest up to $8 million in the company over the next two years.

 

The transaction, which is subject to regulatory approval, involves a commitment of $400,000 per month over twenty months, and is a debenture convertible into common stock and warrants to purchase common stock.

 

DNA Print, of Sarasota, Fla., said it will use the financing to hire personnel, expand its operations including its clinical pharmacogenomics program, and pursue business in pharmacogenomics, forensic, and consumer products.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.